Follow
Ronan Jolivel
Ronan Jolivel
HEVA
No verified email
Title
Cited by
Cited by
Year
Immunotherapy rechallenge after nivolumab treatment in advanced non-small cell lung cancer in the real-world setting: a national data base analysis
MG Levra, FE Cotté, R Corre, C Calvet, AF Gaudin, JR Penrod, ...
Lung Cancer 140, 99-106, 2020
1012020
Outcome following nivolumab treatment in patients with advanced non-small cell lung cancer and comorbid interstitial lung disease in a real-world setting
JB Assié, C Chouaïd, H Nunes, D Reynaud, AF Gaudin, V Grumberg, ...
Therapeutic Advances in Medical Oncology 15, 17588359231152847, 2023
52023
MA07. 06 Immunotherapy Re-Challenge After Nivolumab Treatment in Advanced Non-Small Cell Lung Cancer in French Real-World Setting
MG Levra, F Cotté, R Corre, C Calvet, B Jouaneton, R Jolivel, A Gaudin, ...
Journal of Thoracic Oncology 14 (10), S274-S275, 2019
32019
P2. 04-03 Nivolumab Outcomes in Octogenarian Patients with Advanced Non-Small Cell Lung Cancer in French Real-World Setting
J Assié, F Cotte, MG Levra, C Calvet, R Jolivel, B Jouaneton, A Gaudin, ...
Journal of Thoracic Oncology 14 (10), S708, 2019
32019
Revascularisation for Peripheral Arterial Disease in France: Implications for the Implementation of VOYAGER-PAD
V Aboyans, O Morboeuf, B Grenier, R Jolivel, A Bura-Riviere
European Journal of Vascular and Endovascular Surgery, 2024
22024
Long-term hospital resource utilization and associated costs of care for patients initiating nivolumab in advanced non-small cell lung cancer in France
V Grumberg, C Chouaïd, FE Cotté, B Jouaneton, R Jolivel, AF Gaudin, ...
Journal of Medical Economics 25 (1), 691-699, 2022
22022
Couts des hospitalisations et des soins de suite et de réadaptation liés au COVID-19 en France en 2020
S Gallien, C Guilmet, A Hurtes, H Omichessan, F Messaoudi, A Panes, ...
Médecine et Maladies Infectieuses Formation 1 (2), S51, 2022
22022
Nivolumab treatment in advanced non-small cell lung cancer (aNSCLC): A French nationwide retrospective cohort (UNIVOC Study)
C Chouaid, MG Levra, R Corre, C Calvet, AF Gaudin, V Grumberg, ...
Annals of Oncology 30, v521, 2019
22019
Patients en vie 5 ans après l’initiation de nivolumab dans le cancer bronchique non à petites cellules métastatique: caractéristiques, prise en charge et consommations de soins
JB Assié, FE Cotté, D Reynaud, AF Gaudin, V Grumberg, R Jolivel, ...
Revue des Maladies Respiratoires Actualités 15 (1), 237, 2023
12023
101P Nivolumab outcomes in interstitial lung disease patients with advanced non-small cell lung cancer in French real-world setting
JB Assie, C Chouaïd, H Nunes, D Reynaud, AF Gaudin, V Grumberg, ...
Annals of Oncology 32, S1418, 2021
12021
Characteristics, management, and healthcare resources of patients with advanced non–small-cell lung cancer surviving 5 years after nivolumab treatment initiation: A national …
JB Assié, V Grumberg, D Reynaud, AF Gaudin, A Batisse, R Jolivel, ...
Respiratory Medicine and Research 84, 101051, 2023
2023
EPH15 Epidemiology of Patients Revascularized for Peripheral Artery Disease in France (2016-19): A Retrospective Observational Cohort Study Using the French Hospital Discharge …
V Aboyans, H Miadi, O Morboeuf, E Piettre, R Jolivel, A Bura-Rivière
Value in Health 25 (12), S193, 2022
2022
POSA300 Combining Clinical Trial and Real-World Evidence Data in the Assessment of Public Health Impact in HTA Evaluations
H Leleu, A Nucit, C Lefevre, O Salvignol, B Grenier, C Coulibaly, R Jolivel, ...
Value in Health 25 (1), S198, 2022
2022
POSC418 Long-Term Evolution of Hospital Resource Utilization and Associated Costs Using Adjustment Methods: in Patients Treated with Nivolumab for Advanced Non-Small Cell Lung …
V Grumberg, C Chouaid, FE Cotte, B Jouaneton, R Jolivel, AF Gaudin, ...
Value in Health 25 (1), S271, 2022
2022
PCN138 Study of the Burden of Blood Transfusions in Patients with Lower-Risk Myelodysplastic Syndromes Who Receive Regular Transfusions
G Jeanblanc, Q Roset, A Schmidt, B Jouaneton, R Jolivel
Value in Health 23, S448, 2020
2020
PCN348 Long-Term Healthcare Resource Utilization and Costs Associated with Patients Treated with Nivolumab for Advanced Non-Small Cell Lung Cancer
V Grumberg, FE Cotte, B Jouaneton, R Jolivel, R Corre, M Giaj-Levra, ...
Value in Health 23, S484, 2020
2020
PDB74 USING FRENCH ADMINISTRATIVE DATABASE TO ASSESS PATIENTS WITH ADVANCED NON-ALCOHOLIC STEATOHEPATITIS (NASH)
V Ratziu, F Raguideau, R Jolivel, A Vainchtock, I Rodriguez, A Abergel
Value in Health 22, S586, 2019
2019
Prise en charge hospitalière des exacerbations de BPCO et impact sur les réadmissions en France
L De Léotoing, B Melloni, A Cavailles, T Flament, G Berthon, F Raguideau, ...
Revue des Maladies Respiratoires 36, A66, 2019
2019
PRS30-HOSPITAL MANAGEMENT OF ACUTE COPD EXACERBATION AND IMPACT ON HOSPITAL RE-ADMISSION IN FRANCE
L de Léotoing, B Melloni, A Cavaillès, T Flament, F Raguideau, R Jolivel, ...
Value in Health 21, S408-S409, 2018
2018
PND109-SICKLE-CELL DISEASE RELATED HOSPITALIZATIONS IN FRANCE: A REGIONAL DESCRIPTIVE ANALYSIS FROM THE FRENCH MEDICAL INFORMATION SYSTEM DATABASE IN 2016
E Duteil, F Raguideau, R Jolivel, A Pagniez, L Lamarsalle
Value in Health 21, S347, 2018
2018
The system can't perform the operation now. Try again later.
Articles 1–20